Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
74,190,609
-
Total 13F shares
-
17,249,571
-
Share change
-
-1,264,216
-
Total reported value
-
$8,105,940
-
Price per share
-
$0.47
-
Number of holders
-
30
-
Value change
-
-$763,733
-
Number of buys
-
6
-
Number of sells
-
16
Institutional Holders of ENZON PHARMACEUTICALS, INC. - Common Stock, par value $0.01 per share (ENZN) as of Q1 2016
As of 31 Mar 2016,
ENZON PHARMACEUTICALS, INC. - Common Stock, par value $0.01 per share (ENZN) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,249,571 shares.
The largest 10 holders included
ICAHN CARL C, RENAISSANCE TECHNOLOGIES LLC, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, UBS Group AG, BLACKROCK ADVISORS LLC, Connor, Clark & Lunn Investment Management Ltd., JACOBS LEVY EQUITY MANAGEMENT, INC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.